Bluebird Bio | L'Utile Ante Imposte



L'Utile Ante Imposte Cambiamento Data
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Arrowhead Research USD 28.27M 7.85M 2025-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
Incyte USD 389.94M 92.37M 2025-12
Ionis Pharmaceuticals USD -129M 253M 2025-09
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Tectonic Therapeutic USD -19.04M 25K 2025-09
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Bluebird Bio L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.